* CV Therapeutics Inc., of Palo Alto, Calif., elected Isaac Stein to itsboard of directors. He is president of a private investment firm.* IntraBiotics Pharmaceuticals Inc., of Palo Alto, Calif., named LeoChee-Liang Gu senior director, pharmaceutical development, andDeborah Steinberg as director of microbiology.* Genzyme Corp., of Cambridge, Mass., promoted Bonnie Fendrockto vice president, surgical products.* U.S. Bioscience Inc., of West Conshohocken, Pa., appointedMichael Kurman vice president, clinical research.* Argonex Inc., of The Woodlands, Texas, said David Leech willserve as CEO, James Chubb will be president and chief operatingofficer. Both also will be directors of the company, formed as a resultof the three-way merger of Argus Pharmaceuticals Inc., TriplexPharmaceutical Corp. and Oncologix Inc.
(c) 1997 American Health Consultants. All rights reserved.